abstract |
The present invention relates to a composition for early diagnosis of hepatocellular carcinoma using WASF2 autoantibody, and the present invention can easily diagnose early hepatocellular carcinoma using a non-invasive biological sample such as a patient's blood without using biopsy and imaging techniques. A composition is provided. By using the present invention, the expression level of WASF2-recognizing autoantibodies present in the blood can be measured, and through this, hepatocellular carcinoma can be diagnosed early. |